Equity Overview
Price & Market Data
Price: $0.0167
Daily Change: -$0.00465 / 27.84%
Daily Range: $0.0167 - $0.0167
Market Cap: $2,734,229
Daily Volume: 4,000
Performance Metrics
1 Week: -21.78%
1 Month: -21.78%
3 Months: -21.78%
6 Months: -21.78%
1 Year: -66.60%
YTD: %
Details
Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication; Midkine RNA oligonucleotide therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics for solid tumors; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and natural killer cell-mediated anti-cancer action. The company was incorporated in 2020 and is based in London, the United Kingdom.